SHOX2 and lung cancer: In 2011, SHOX2 methylation was assessed in circulating cell-free DNA obtained from blood plasma and showed a sensitivity of 60% and a specificity of 90% for lung cancer diagnosis in a case-control study with 343 subjects (Kneip et al., 2011).